Effectiveness of respiratory rehabilitation in patients with <scp>COVID</scp>‐19: A meta‐analysis

Ashra, Fauzi; Jen, Hsiu‐Ju; Liu, Doresses; Lee, Tso-Ying; Pien, Li-Chung; Chen, Ruey; Lin, Hui-Chen; Chou, Kuei‐Ru

doi:10.1111/jocn.16692

Cited by 7 publications

(1 citation statement)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The respiratory telerehabilitation programs were heterogeneous among themselves with the most repeated parameters being 6 weeks of treatment at least three times a week with a duration of 20 to 60 min per session. These parameters are in line with the parameters of different pulmonary telerehabilitation programs presented in a review carried out in patients with COVID-19 [ 50 ]. Due to the pandemic situation in which the studies included in this review were carried out, all the interventions were performed at home [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 ], and most of them were monitored [ 37 , 38 , 40 , 41 , 43 , 44 , 45 ].…”

Section: Discussionsupporting

confidence: 77%

Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis

Calvache-Mateo,

Heredia-Ciuró,

Martín-Núñez

et al. 2023

Healthcare

View full text Add to dashboard Cite

The aim of this review was to identify, map, and synthesize the extent and nature of research activity on the use of telerehabilitation to support Long COVID-19 rehabilitation and examine the efficacy and safety of respiratory telerehabilitation in patients with Long COVID-19. A systematic review and meta-analysis of randomized controlled trials were performed. We included controlled trials that tested the effect of respiratory telerehabilitation interventions in patients with Long COVID-19 versus no intervention, usual care, placebo, or face-to-face intervention. The data were pooled, and a meta-analysis was completed for quality of life, dyspnea, lung function, anxiety and depression, respiratory muscle strength, functional capacity, and lower limb strength. Finally, 10 studies were included. The meta-analysis results show significant differences in favor of respiratory telerehabilitation in quality of life (p = 0.02), dyspnea (p < 0.00001), respiratory muscle strength (p < 0.001), functional capacity (p < 0.0001), and lower limb strength (p = 0.01) but not in lung function (p = 0.28) and anxiety and depression (p = 0.55). In addition, there were no statistically significant differences in adverse effects (p = 0.06) between the telerehabilitation and comparator groups. The results suggest that these interventions can improve quality of life, reduce dyspnea, and increase respiratory and lower extremity muscle strength as well as functional capacity in patients with Long COVID-19.

show abstract

Section: Discussionsupporting

confidence: 77%

Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis

Calvache-Mateo,

Heredia-Ciuró,

Martín-Núñez

et al. 2023

Healthcare

View full text Add to dashboard Cite

show abstract

Krankheitsassoziierte Testverfahren und medizinische Trainingstherapie innerer Erkrankungen

Wolfram,

Bauer

2024

Evidenzbasierte Medizinische Trainingstherapie

View full text Add to dashboard Cite

Impact of COVID infection on lung function test and quality of life

Toh,

Teo,

Poh

et al. 2023

Sci Rep

View full text Add to dashboard Cite

Post-COVID-19 pulmonary sequalae are well-recognized early in the pandemic. Survivorship clinics are crucial for managing at-risk patients. However, it is unclear who requires pulmonary function test (PFT) and when PFTs should be performed. We aim to investigate for whom and how these interval PFTs should be performed. We performed a single-centre, prospective cohort study on COVID-19 survivors between 1st May 2020 and 31st April 2022. These patients were followed up at 6, 9 and 12 months with interval PFT and Short Form-36 (SF-36) Health Survey. Those with PFT defects were offered a computed tomography scan of the thorax. Of the 46 patients recruited, 17 (37%) had severe/critical illness. Compared to those with mild/moderate disease, these patients were more likely to experience DLCO defects (59% versus 17%, p = 0.005) and had lower SF-36 scores (mean physical component summary score of 45 ± 12 versus 52 ± 8, p = 0.046). These differences were most notable at 6 months, compared to the 9- and 12-months intervals. DLCO defects were also associated with older age, raised inflammatory markers and extensive CXR infiltrates. Besides interstitial-like abnormalities, obesity and undiagnosed lung conditions accounted for 39% of the PFT abnormalities. Interval PFTs can be performed earliest 6 months post-COVID-19. Patients with normal tests were unlikely to develop new abnormalities and would not require repeat PFTs. Abnormal PFTs can be followed-up with repeat PFTs 6 monthly until resolution. Non-COVID-19 differentials should be considered for persistent PFT abnormalities.

show abstract

Effectiveness of respiratory rehabilitation in patients with COVID‐19: A meta‐analysis

Cited by 7 publications

References 47 publications

Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis

Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis

Krankheitsassoziierte Testverfahren und medizinische Trainingstherapie innerer Erkrankungen

Impact of COVID infection on lung function test and quality of life

Contact Info

Product

Resources

About